Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
1 of 6
Previous |
Next
Drug Discovery
Peptide microarrays in protein kinase and nuclear receptor research
Dr Rob Ruijtenbeek, VP Biological Sciences, PamGene International BV, Nieuwstraat 30,
5211NL ‘s-Hertogenbosch, The Netherlands
No Comments
Asterand PhaseZERO - a solution for Drug Development
By Robert A Coleman, PhD, Asterand plc
No Comments
The New Pharma Landscape
The pharmaceutical industry has found itself beset by problems in recent years, not least the slowing of the blockbuster model. How can the sector shake off its lethargy? By Neil Davey
No Comments
It’s All in the Genes
Frances Davies looks at why the genomics revolution is transforming modern medicine. Genetics and its successor genomics is currently one of the most hotly tipped scientific fields, with an enormous potential to revolutionize medicine and provide new therapeutic treatment for diseases.
No Comments
1 of 6
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.